Drugmaker Pfizer Abandons AstraZeneca Takeover Bid

@AFP
Drugmaker Pfizer Abandons AstraZeneca Takeover Bid

New York (AFP) – U.S. drugmaker Pfizer said on Monday it would abandon its controversial bid to acquire British rival AstraZeneca after its final $117-billion offer was rejected last week.

“Following the AstraZeneca board’s rejection of the proposal, Pfizer announces that it does not intend to make an offer for AstraZeneca,” the New York-based company said in a statement.

The announcement put an end to a long-running saga that drew widespread attention over fears that British jobs and research capability would be lost and accusations that the tie-up was a cynical ploy by Pfizer to pay less tax.

Pfizer had said that the combined company would deliver an expanded product pipeline, deep potential cost cuts and significant tax savings.

“We continue to believe that our final proposal was compelling and represented full value for AstraZeneca based on the information that was available to us,” said Ian Read, chairman and CEO of Pfizer in the statement.

Pfizer’s proposal also included a controversial plan to re-domicile the combined company in Britain for tax purposes, in a move that would help it avoid paying billions of dollars in tax to the US government.

Pfizer’s play for AstraZeneca comes as global pharmaceutical giants maneuver to cope with lost revenues from public sector cutbacks in health care, and patent expirations.

AFP Photo/Mario Tama

Start your day with National Memo Newsletter

Know first.

The opinions that matter. Delivered to your inbox every morning

How Selling More DJT Stock Makes Trump Richer -- And Shareholders Poorer

Trump Media share price shows steep decline following its peak in late March

Image by Wall Street Journal

Trump plans to water DJT stock by issuing millions of new shares. It’s part of a new Trump scheme to make money for himself and his bankers from a failing company that rang up just $4.1 million in revenue last year and lost more than $58 million.

Keep reading...Show less
Joe Biden

President Joe Biden

A new Civiqs poll for Daily Kos shows why the issue of abortion is so perilous for the Republican Party, with voters viewing themselves as significantly more aligned with Democrats on the matter.

Keep reading...Show less
{{ post.roar_specific_data.api_data.analytics }}